Global Sickle Cell Anemia Therapeutics Competitive Landscape Professional Research Report 2024

Research Summary

Sickle cell anemia therapeutics encompass a range of treatments aimed at managing the symptoms and complications associated with sickle cell disease (SCD), a genetic disorder characterized by abnormal hemoglobin production. Therapeutic approaches for sickle cell anemia may include disease-modifying medications such as hydroxyurea, which increases fetal hemoglobin production and reduces the frequency of painful vaso-occlusive crises. Other treatments target specific complications of SCD, such as blood transfusions to alleviate anemia or prevent stroke, pain management strategies for acute and chronic pain episodes, and antibiotic prophylaxis to reduce the risk of infections. Additionally, advances in gene therapy and stem cell transplantation offer potential curative options for select patients with sickle cell anemia. Overall, the goal of sickle cell anemia therapeutics is to improve quality of life, prevent complications, and potentially cure the disease through targeted interventions tailored to individual patients' needs.

According to DIResearch's in-depth investigation and research, the global Sickle Cell Anemia Therapeutics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Sickle Cell Anemia Therapeutics include Emmaus Medical, Addmedica, Gamida Cell, GlycoMimetics, Pfizer, Novartis, Global Blood Therapeutics, Micelle BioPharma, Bluebird Bio, Prolong Pharmaceuticals, Sangamo Biosciences, Modus Therapeutics, Imara, Bioverativ, Ironwood Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Sickle Cell Anemia Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Sickle Cell Anemia Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Sickle Cell Anemia Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Sickle Cell Anemia Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Sickle Cell Anemia Therapeutics Include:

Emmaus Medical

Addmedica

Gamida Cell

GlycoMimetics

Pfizer

Novartis

Global Blood Therapeutics

Micelle BioPharma

Bluebird Bio

Prolong Pharmaceuticals

Sangamo Biosciences

Modus Therapeutics

Imara

Bioverativ

Ironwood Pharmaceuticals

Sickle Cell Anemia Therapeutics Product Segment Include:

Blood Transfusion

Pharmacotherapy

Bone Marrow Transplant

Sickle Cell Anemia Therapeutics Product Application Include:

Child

Adult

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Sickle Cell Anemia Therapeutics Industry PESTEL Analysis

Chapter 3: Global Sickle Cell Anemia Therapeutics Industry Porter's Five Forces Analysis

Chapter 4: Global Sickle Cell Anemia Therapeutics Major Regional Market Size and Forecast Analysis

Chapter 5: Global Sickle Cell Anemia Therapeutics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Sickle Cell Anemia Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Sickle Cell Anemia Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Sickle Cell Anemia Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Sickle Cell Anemia Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Sickle Cell Anemia Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Sickle Cell Anemia Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Sickle Cell Anemia Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Sickle Cell Anemia Therapeutics Market Overview

1.1 Product Definition and Statistical Scope

1.2 Sickle Cell Anemia Therapeutics Product by Type

1.2.1 Global Sickle Cell Anemia Therapeutics Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Blood Transfusion

1.2.3 Pharmacotherapy

1.2.4 Bone Marrow Transplant

1.3 Sickle Cell Anemia Therapeutics Product by Application

1.3.1 Global Sickle Cell Anemia Therapeutics Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Child

1.3.3 Adult

1.4 Global Sickle Cell Anemia Therapeutics Market Revenue Analysis (2019-2030)

1.5 Sickle Cell Anemia Therapeutics Market Development Status and Trends

1.5.1 Sickle Cell Anemia Therapeutics Industry Development Status Analysis

1.5.2 Sickle Cell Anemia Therapeutics Industry Development Trends Analysis

2 Sickle Cell Anemia Therapeutics Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Sickle Cell Anemia Therapeutics Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Sickle Cell Anemia Therapeutics Market Analysis by Regions

4.1 Sickle Cell Anemia Therapeutics Overall Market: 2023 VS 2024 VS 2030

4.2 Global Sickle Cell Anemia Therapeutics Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Sickle Cell Anemia Therapeutics Revenue and Market Share by Region (2019-2024)

4.2.2 Global Sickle Cell Anemia Therapeutics Revenue Forecast by Region (2025-2030)

5 Global Sickle Cell Anemia Therapeutics Market Size by Type and Application

5.1 Global Sickle Cell Anemia Therapeutics Market Size by Type

5.2 Global Sickle Cell Anemia Therapeutics Market Size by Application

6 North America

6.1 North America Sickle Cell Anemia Therapeutics Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Sickle Cell Anemia Therapeutics Market Size by Type

6.4 North America Sickle Cell Anemia Therapeutics Market Size by Application

6.5 North America Sickle Cell Anemia Therapeutics Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Sickle Cell Anemia Therapeutics Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Type

7.4 Europe Sickle Cell Anemia Therapeutics Market Size by Application

7.5 Europe Sickle Cell Anemia Therapeutics Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Sickle Cell Anemia Therapeutics Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Sickle Cell Anemia Therapeutics Market Size by Type

8.4 China Sickle Cell Anemia Therapeutics Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Sickle Cell Anemia Therapeutics Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Sickle Cell Anemia Therapeutics Market Size by Type

9.4 APAC (excl. China) Sickle Cell Anemia Therapeutics Market Size by Application

9.5 APAC (excl. China) Sickle Cell Anemia Therapeutics Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Sickle Cell Anemia Therapeutics Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Sickle Cell Anemia Therapeutics Market Size by Type

10.4 Latin America Sickle Cell Anemia Therapeutics Market Size by Application

10.5 Latin America Sickle Cell Anemia Therapeutics Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type

11.4 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application

11.5 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Sickle Cell Anemia Therapeutics Market Revenue by Key Manufacturers (2020-2024)

12.2 Sickle Cell Anemia Therapeutics Competitive Landscape Analysis and Market Dynamic

12.2.1 Sickle Cell Anemia Therapeutics Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Emmaus Medical

13.1.1 Emmaus Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Emmaus Medical Sickle Cell Anemia Therapeutics Product Portfolio

13.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Addmedica

13.2.1 Addmedica Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Addmedica Sickle Cell Anemia Therapeutics Product Portfolio

13.2.3 Addmedica Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Gamida Cell

13.3.1 Gamida Cell Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Gamida Cell Sickle Cell Anemia Therapeutics Product Portfolio

13.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 GlycoMimetics

13.4.1 GlycoMimetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 GlycoMimetics Sickle Cell Anemia Therapeutics Product Portfolio

13.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Pfizer

13.5.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Pfizer Sickle Cell Anemia Therapeutics Product Portfolio

13.5.3 Pfizer Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Novartis

13.6.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Novartis Sickle Cell Anemia Therapeutics Product Portfolio

13.6.3 Novartis Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Global Blood Therapeutics

13.7.1 Global Blood Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product Portfolio

13.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Micelle BioPharma

13.8.1 Micelle BioPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Micelle BioPharma Sickle Cell Anemia Therapeutics Product Portfolio

13.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Bluebird Bio

13.9.1 Bluebird Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Bluebird Bio Sickle Cell Anemia Therapeutics Product Portfolio

13.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Prolong Pharmaceuticals

13.10.1 Prolong Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product Portfolio

13.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Sangamo Biosciences

13.11.1 Sangamo Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Sangamo Biosciences Sickle Cell Anemia Therapeutics Product Portfolio

13.11.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Modus Therapeutics

13.12.1 Modus Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Modus Therapeutics Sickle Cell Anemia Therapeutics Product Portfolio

13.12.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Imara

13.13.1 Imara Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Imara Sickle Cell Anemia Therapeutics Product Portfolio

13.13.3 Imara Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Bioverativ

13.14.1 Bioverativ Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Bioverativ Sickle Cell Anemia Therapeutics Product Portfolio

13.14.3 Bioverativ Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Ironwood Pharmaceuticals

13.15.1 Ironwood Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product Portfolio

13.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Sickle Cell Anemia Therapeutics Industry Chain Analysis

14.2 Sickle Cell Anemia Therapeutics Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Sickle Cell Anemia Therapeutics Typical Downstream Customers

14.4 Sickle Cell Anemia Therapeutics Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support